Effect-time-relation of the H1-receptor antagonist dimethindene maleate following intravenous injection. 1990

D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
Zyma GmbH, Hauptabteilung Medizinische Entwicklung, München, FRG.

We have investigated the time-course of the weal and flare inhibiting activity of dimethindene maleate in man and compared the resulting effect-kinetic data with those from pharmacokinetic investigations. The study was carried out in a double blind, placebo controlled cross-over design with randomly assigned healthy volunteers. Dimethindene maleate (4 mg) was intravenously injected, followed by intracutaneous histamine provocations (-1, 2, 5, 14, 17, 20, 23, 26, and 29 h). The two cross-over periods were separated by a wash-out phase of 17 h. Flare and weal areas were documented 5, 10, 20, and 30 min after provocation with histamine. A strong inhibition of the development of flares and weals was observed and was more pronounced in flares than in weals. With regard to the time course of the inhibiting effect, its maxima both for flares and weals were observed at a provocation time of 2 h. The mean residence time of the inhibiting effect was calculated to be ca. 13 h for flares and ca. 15 h for weals. These values are nearly 2-3 times as high as the mean residence time of 6 h calculated from blood level data. Blood- and effect-levels are thus non-linearly related.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D004115 Dimethindene A histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies. Dimethpyrindene,Dimethindene Maleate,Dimetindene,Fenistil,Forhistal,Maleate, Dimethindene
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
April 1992, Methods and findings in experimental and clinical pharmacology,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
February 1987, British journal of clinical pharmacology,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 1994, International archives of allergy and immunology,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
May 2005, International archives of allergy and immunology,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
January 1991, The Journal of international medical research,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
April 1964, Southern medical journal,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
July 1996, Die Pharmazie,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
October 1973, Zeitschrift fur Hautkrankheiten,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
February 1985, British journal of clinical pharmacology,
D Rehn, and H Geissler, and U Schönbrunn, and H Lukas, and G Hennings
November 1995, European journal of pharmacology,
Copied contents to your clipboard!